We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Generic firm Mylan Pharmaceuticals will seek an immediate appeal of a federal court ruling that prevents it from an early launch of a generic version of Johnson & Johnson’s pain-drug patch, Duragesic.